Approvals/TGA/DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial

Approved

STANDARD

DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ffe16b38e1902437
Product Name: DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial
Artg Id: 12300
Artg Name: DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 1991-08-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3bc149e17f0c1cf00f220ccba84baa03.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b9b9784e53ac43a4fcb48fb2b1d9cc24.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ffe16b38e1902437

Type

Standard